Cell line · CVCL_0417
Papers45
1 to 20 of 45
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumors. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HTS384 NCI60: The Next Phase of the NCI60 Screen. | Cancer Res | 2024 | Cellosaurus cites it, and its Methods give the RRID and name the line | PubMed | |
| Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils. | Cancers (Basel) | 2024 | Its Methods give the RRID and name the line | PubMed | |
| eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer. | Sci Signal | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors. | Cell Rep Med | 2021 | Its Methods give the RRID and name the line | PubMed | |
| YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models. | Cell Oncol (Dordr) | 2021 | Its Methods give the RRID and name the line | PubMed | |
| 89Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo. | Cancers (Basel) | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines. | iScience | 2019 | Cellosaurus cites it | PubMed | |
| Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line. | Int J Cancer | 2018 | Cellosaurus cites it | PubMed | |
| Multidimensional phenotyping of breast cancer cell lines to guide preclinical research. | Breast Cancer Res Treat | 2018 | Cellosaurus cites it | PubMed | |
| A map of mobile DNA insertions in the NCI-60 human cancer cell panel. | Mob DNA | 2016 | Cellosaurus cites it | PubMed | |
| A Landscape of Pharmacogenomic Interactions in Cancer. | Cell | 2016 | Cellosaurus cites it | PubMed | |
| Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR. | Sci Data | 2016 | Cellosaurus cites it | PubMed | |
| Continued use of MDA-MB-435, a melanoma cell line, as a model for human breast cancer, even in year, 2014. | NPJ Breast Cancer | 2015 | Cellosaurus cites it | PubMed | |
| TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression. | Genome Med | 2015 | Cellosaurus cites it | PubMed | |
| A resource for cell line authentication, annotation and quality control. | Nature | 2015 | Cellosaurus cites it | PubMed | |
| A comprehensive transcriptional portrait of human cancer cell lines. | Nat Biotechnol | 2015 | Cellosaurus cites it | PubMed | |
| High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner. | PLoS One | 2014 | Cellosaurus cites it | PubMed | |
| The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. | Cancer Metab | 2013 | Cellosaurus cites it | PubMed | |
| Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. | Breast Cancer Res Treat | 2013 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0417/papers